In sensitivity analyses using the Alzheimer’s disease GWAS excluding UKB, the estimates for the effect of APOC1 were directionally consistent with our main findings but the confidence intervals were not overlapping (Supplementary Tables 7, 8). This evidence concerns the gene APOC1 and Alzheimer disease.